Metaomics in Clinical Laboratory: Potential Driving Force for Innovative Disease Diagnosis
Liang Wang,Fen Li,Bin Gu,Pengfei Qu,Qinghua Liu,Junjiao Wang,Jiawei Tang,Shubin Cai,Qi Zhao,Zhong Ming
DOI: https://doi.org/10.3389/fmicb.2022.883734
IF: 5.2
2022-06-18
Frontiers in Microbiology
Abstract:Currently, more and more studies suggested that reductionism was lack of holistic and integrative view of biological processes, leading to limited understanding of complex systems like microbiota and the associated diseases. In fact, microbes are rarely present in individuals but normally live in complex multispecies communities. With the recent development of a variety of metaomics techniques, microbes could be dissected dynamically in both temporal and spatial scales. Therefore, in-depth understanding of human microbiome from different aspects such as genomes, transcriptomes, proteomes, and metabolomes could provide novel insights into their functional roles, which also holds the potential in making them diagnostic biomarkers in many human diseases, though there is still a huge gap to fill for the purpose. In this mini-review, we went through the frontlines of the metaomics techniques and explored their potential applications in clinical diagnoses of human diseases, e.g., infectious diseases, through which we concluded that novel diagnostic methods based on human microbiomes shall be achieved in the near future, while the limitations of these techniques such as standard procedures and computational challenges for rapid and accurate analysis of metaomics data in clinical settings were also examined.
microbiology